Thoracolumbar fractures are the most common spinal fractures with an average annual incidence between 18 and 30 per 100'000 inhabitants. The majority of these fractures are AO type A3 ("burst fractures"). Although patients with burst fractures report a reduced quality of life and chronic pain, there is no clear evidence whether surgical or conservative treatment offer better functional and back-pain related outcomes. The indications for the selection of an ideal treatment for these fractures without neurological deficits remain controversial. The purpose of this study is to evaluate whether patients with thoracolumbar fractures without neurological deficit being surgically treated show faster recovery and better improvement of function than patients being conservatively treated.
Study Type
OBSERVATIONAL
Enrollment
38
Hospital Universitaria Cajuru
Curitiba, Brazil
Hospital Cristo Redentor
Porto Alegre, Brazil
Hospital Santa Marcelina
São Paulo, Brazil
Hospital Cristo Redentor
Santiago, Chile
Krajská nemocnice Liberec
Liberec, Czechia
Klinikum rechts der Isar der Technischen Universität München
Munich, Germany
Azienda Ospedaliero - Universitaria Policlinico
Catania, Italy
Hospital Garcia e Orta, EPE
Almada, Portugal
Roland-Morris Disability Questionnaire (RMDQ)
Improvement in functional outcome from baseline to 6 week follow up (FU) measured with the Roland-Morris Disability Questionnaire (RMDQ)
Time frame: 6 week follow up
Back pain related disability (Roland-Morris Disability Questionnaire RMDQ)
Time frame: Assessed at baseline, 6 weeks, 3, 6, 12 and 24 months follow up
Pain (Numeric Rating Scale (NRS))
Time frame: Assessed at baseline, 6 weeks, 3, 6, 12 and 24 months FU
Radiologic progress taking into account RX, CT and optionally MRI
Time frame: baseline and at follow up after 6 weeks, 3, 6, 12 and 24 months
Quality of return to work (Denis Work Scale)
Time frame: Assessed at baseline, 6 weeks, 3, 6, 12 and 24 months follow up
Time to return to work
Time frame: Assessed at baseline, 6 weeks, 3, 6, 12 and 24 months follow up
Conservative treatment failure rate (eg, change to surgical treatment)
Time frame: Assessed at baseline, 6 weeks, 3, 6, 12 and 24 months follow up
Rates of local adverse events (AE)
Time frame: Assessed at baseline, 6 weeks, 3, 6, 12 and 24 months follow up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.